Randall Kaye
Vermogen: 331 200 $ op 31-05-2026
Vermogen: 331 200 $ op 31-05-2026
Randall E.
Kaye is an Independent Non-Executive Director at NervGen Pharma Corp.
since 2020.
Former roles include Vice President-Medical Affairs at Scios, Inc. from 2004 to 2006; Chief Medical Officer & SVP-Medical Affairs at Avanir Pharmaceuticals, Inc. from 2013 to 2014; Vice President-Medical Affairs at InterMune, Inc.; Chief Medical Officer at Axsome Therapeutics, Inc. from 2014 to 2016; Chief Medical Officer at Click Therapeutics, Inc. from 2018 to 2019; Chief Medical Officer & EVP at Longboard Pharmaceuticals, Inc.; Chief Scientific Officer at SSI Strategy LLC from 2014 to 2018; and Chief Medical Officer at Neurana Pharmaceuticals, Inc. Education includes undergraduate, graduate, and doctorate degrees from George Washington University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-01-2026 | 160.000 ( 0,2% ) | 331 200 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur/Bestuurslid | 28-10-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Hoofd Techniek/Wetenschap/O&O | 01-09-2019 |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services Provides bio-tech sciences consulting services | Corporate Officer/Principal | 01-09-2018 |
| AXSOME THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2016 |
| AVANIR PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-09-2014 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Technology Services |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services Provides bio-tech sciences consulting services | Commercial Services |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau